🇺🇸 US

TXG earnings report dates and EPS history (10x Genomics, Inc.)

Quick answer

10x Genomics, Inc. (TXG) reported diluted EPS of $-0.14 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-07. Its last four 10-Q/10-K filings were on 2026-08-07, 2026-05-08, 2026-02-13, 2025-11-07.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2026-08-07. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Period endPeriodFormSEC filing dateDiluted EPS
2026-06-30Quarter10-Q2026-08-07$-0.14
2026-03-31Quarter10-Q2026-05-08$-0.10
2025-12-31Full year10-K2026-02-13$-0.35
2025-09-30Quarter10-Q2025-11-07$-0.22
2025-06-30Quarter10-Q2025-08-08$0.28
2025-03-31Quarter10-Q2025-05-09$-0.28
2024-12-31Full year10-K2025-02-13$-1.52
2024-09-30Quarter10-Q2024-10-29$-0.30
2024-06-30Quarter10-Q2024-08-08$-0.32
2024-03-31Quarter10-Q2024-04-30$-0.50
2023-12-31Full year10-K2024-02-15$-2.18
2023-09-30Quarter10-Q2023-11-03$-0.79
2023-06-30Quarter10-Q2023-08-04$-0.53
2023-03-31Quarter10-Q2023-05-04$-0.44
2022-12-31Full year10-K2023-02-16$-1.46
2022-09-30Quarter10-Q2022-11-03$-0.37

Related

Last updated 2026-10-16. Data only, not financial or tax advice.